» Articles » PMID: 20651255

Voltage-gated Na+ Channel SCN5A is a Key Regulator of a Gene Transcriptional Network That Controls Colon Cancer Invasion

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Jul 24
PMID 20651255
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Voltage-gated Na(+) channels (VGSC) have been implicated in the metastatic potential of human breast, prostate, and lung cancer cells. Specifically, the SCN5A gene encoding the VGSC isotype Na(v)1.5 has been defined as a key driver of human cancer cell invasion. In this study, we examined the expression and function of VGSCs in a panel of colon cancer cell lines by electrophysiologic recordings. Na(+) channel activity and invasive potential were inhibited pharmacologically by tetrodotoxin or genetically by small interfering RNAs (siRNA) specifically targeting SCN5A. Clinical relevance was established by immunohistochemistry of patient biopsies, with strong Na(v)1.5 protein staining found in colon cancer specimens but little to no staining in matched-paired normal colon tissues. We explored the mechanism of VGSC-mediated invasive potential on the basis of reported links between VGSC activity and gene expression in excitable cells. Probabilistic modeling of loss-of-function screens and microarray data established an unequivocal role of VGSC SCN5A as a high level regulator of a colon cancer invasion network, involving genes that encompass Wnt signaling, cell migration, ectoderm development, response to biotic stimulus, steroid metabolic process, and cell cycle control. siRNA-mediated knockdown of predicted downstream network components caused a loss of invasive behavior, demonstrating network connectivity and its function in driving colon cancer invasion.

Citing Articles

Effects of Na1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer.

Zha Z, Ge F, Li N, Zhang S, Wang C, Gong F Cell Biochem Biophys. 2024; .

PMID: 39673684 DOI: 10.1007/s12013-024-01625-x.


Comprehensive characterization of long QT syndrome-associated genes in cancer and development of a robust prognosis model.

Xu J, Wen Z, She Y, Li M, Shen X, Zhi F J Cell Mol Med. 2024; 28(18):e70094.

PMID: 39317949 PMC: 11421991. DOI: 10.1111/jcmm.70094.


Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.

Giammello F, Biella C, Priori E, Filippo M, Leone R, DAmbrosio F Cell Commun Signal. 2024; 22(1):434.

PMID: 39251990 PMC: 11382371. DOI: 10.1186/s12964-024-01819-z.


A novel Na1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis.

Leslie T, Tripp A, James A, Fraser S, Nelson M, Sajjaboontawee N Oncogene. 2024; 43(34):2578-2594.

PMID: 39048659 PMC: 11329375. DOI: 10.1038/s41388-024-03098-x.


Therapeutic targeting of voltage-gated sodium channel Na1.7 for cancer metastasis.

Pukkanasut P, Jaskula-Sztul R, Gomora J, Velu S Front Pharmacol. 2024; 15:1416705.

PMID: 39045054 PMC: 11263763. DOI: 10.3389/fphar.2024.1416705.


References
1.
Calin G, di Iasio M, Caprini E, Vorechovsky I, Natali P, Sozzi G . Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene. 2000; 19(9):1191-5. DOI: 10.1038/sj.onc.1203389. View

2.
Sokolov S, Scheuer T, Catterall W . Gating pore current in an inherited ion channelopathy. Nature. 2007; 446(7131):76-8. DOI: 10.1038/nature05598. View

3.
Gavillet B, Rougier J, Domenighetti A, Behar R, Boixel C, Ruchat P . Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res. 2006; 99(4):407-14. DOI: 10.1161/01.RES.0000237466.13252.5e. View

4.
Roberts R, Fink G . Elements of a single MAP kinase cascade in Saccharomyces cerevisiae mediate two developmental programs in the same cell type: mating and invasive growth. Genes Dev. 1994; 8(24):2974-85. DOI: 10.1101/gad.8.24.2974. View

5.
Irby R, McCarthy S, Yeatman T . Osteopontin regulates multiple functions contributing to human colon cancer development and progression. Clin Exp Metastasis. 2005; 21(6):515-23. DOI: 10.1007/s10585-004-2873-4. View